Nusantics is the Leading and Most Trusted Precision Molecular Diagnostics Company in Indonesia.
Founded in 2020, Nusantics changed the molecular diagnostics landscape in Indonesia. Our technology has been used in more than 8 million tests during the COVID-19 pandemic. Now, we look to expand our technology to change the way we diagnose communicable diseases and oncology.
At Nusantics, we believe that molecular diagnosis should be accessible, affordable, and at a massive scale. Our products supports our customers across the continuum of molecular diagnostics. From the novel, non-invasive sampling method, DNA and RNA extraction, to PCR and NGS kits targeting single or multiple molecular target, and bioinformatics pipeline to analyze and interpret molecular data to deliver valuable insights.
Our Vision : We envision a healthy world enabled by genomics, microbiomics, and precision medicine.
Our Mission : To close the diagnostics gap and improve healthcare outcome for both humans and animals.